SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: helkel who wrote (2232)3/27/1997 7:34:00 PM
From: richard davis   of 4342
 
Warrant holders of PRLN:

Good news!

Paracelsian, Inc. Announces Extension of Outstanding
Warrants on Common Stock

ITHACA, N.Y., March 27 /PRNewswire/ -- Paracelsian Inc announced today that its Board of
Directors has approved an extension of the warrants for Common Stock through September 6,
1998. The warrants, which were a dividend in September 1993, were scheduled to expire on
September 6, 1997.

Each warrant entities the holder to purchase one share of Common Stock at a price of $3.25. The
Company can redeem the warrants if the sales price of the Common stock exceeds $4.75 for 15
consecutive days. Any warrants not redeemed prior to September 6, 1998, will lapse.

Paracelsian is a biotechnology company engaged in the discovery of useful products from herbal
sources. Its discoveries are accomplished by applying the Company's proprietary screening
technology, based in signal transduction, to its library of extracts used in Traditional Chinese
Medicine. SOURCE Paracelsian Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News